Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 141

1.

Quality assurance of treatment plans for interstitial and intracavitary high-dose-rate brachytherapy.

Das RK, Bradley KA, Nelson IA, Patel R, Thomadsen BR.

Brachytherapy. 2006 Jan-Mar;5(1):56-60.

PMID:
16563998
2.

A comparison between tandem and ovoids and interstitial gynecologic template brachytherapy dosimetry using a hypothetical computer model.

Hsu IC, Speight J, Hai J, Vigneault E, Phillips T, Pouliot J.

Int J Radiat Oncol Biol Phys. 2002 Feb 1;52(2):538-43.

PMID:
11872302
3.

Optimization in high dose rate brachytherapy for utero-vaginal applications.

Cetingöz R, Ataman OU, Tuncel N, Sen M, Kinay M.

Radiother Oncol. 2001 Jan;58(1):31-6.

PMID:
11165679
5.

The Vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer: design, application, treatment planning, and dosimetric results.

Kirisits C, Lang S, Dimopoulos J, Berger D, Georg D, Pötter R.

Int J Radiat Oncol Biol Phys. 2006 Jun 1;65(2):624-30.

PMID:
16690444
6.

CT-Based interstitial HDR brachytherapy.

Kolotas C, Baltas D, Zamboglou N.

Strahlenther Onkol. 1999 Sep;175(9):419-27.

PMID:
10518974
7.

Point vs. volumetric bladder and rectal doses in combined intracavitary-interstitial high-dose-rate brachytherapy: correlation and comparison with published Vienna applicator data.

Yaparpalvi R, Mutyala S, Gorla GR, Butler J, Mah D, Garg MK, Kalnicki S.

Brachytherapy. 2008 Oct-Dec;7(4):336-42. doi: 10.1016/j.brachy.2008.05.005.

PMID:
18782683
8.

The effect of finite patient dimensions and tissue inhomogeneities on dosimetry planning of 192Ir HDR breast brachytherapy: a Monte Carlo dose verification study.

Pantelis E, Papagiannis P, Karaiskos P, Angelopoulos A, Anagnostopoulos G, Baltas D, Zamboglou N, Sakelliou L.

Int J Radiat Oncol Biol Phys. 2005 Apr 1;61(5):1596-602.

PMID:
15817368
9.

Comparison of 2D vs. 3D dosimetry for Rotte 'Y' applicator high dose rate brachytherapy for medically inoperable endometrial cancer.

Beriwal S, Kim H, Heron DE, Selvaraj R.

Technol Cancer Res Treat. 2006 Oct;5(5):521-7.

PMID:
16981795
10.

Conventional high-dose-rate brachytherapy with concomitant complementary IMRT boost: a novel approach for improving cervical tumor dose coverage.

Duan J, Kim RY, Elassal S, Lin HY, Shen S.

Int J Radiat Oncol Biol Phys. 2008 Jul 1;71(3):765-71. doi: 10.1016/j.ijrobp.2007.10.064.

PMID:
18164832
11.

Quality assurance of HDR prostate plans: program implementation at a community hospital.

Rush JB, Thomas MD.

Med Dosim. 2005 Winter;30(4):243-8.

PMID:
16275567
12.

Image-guided cervix high-dose-rate brachytherapy treatment planning: does custom computed tomography planning for each insertion provide better conformal avoidance of organs at risk?

Davidson MT, Yuen J, D'Souza DP, Batchelar DL.

Brachytherapy. 2008 Jan-Mar;7(1):37-42. doi: 10.1016/j.brachy.2007.12.003.

PMID:
18299111
13.

Variation of treatment planning parameters (D90 HR-CTV, D 2cc for OAR) for cervical cancer tandem ring brachytherapy in a multicentre setting: comparison of standard planning and 3D image guided optimisation based on a joint protocol for dose-volume constraints.

Jürgenliemk-Schulz IM, Lang S, Tanderup K, de Leeuw A, Kirisits C, Lindegaard J, Petric P, Hudej R, Pötter R; Gyn GEC ESTRO network..

Radiother Oncol. 2010 Mar;94(3):339-45. doi: 10.1016/j.radonc.2009.10.011.

PMID:
19944471
14.

3D inverse treatment planning for the tandem and ovoid applicator in cervical cancer.

Dewitt KD, Hsu IC, Speight J, Weinberg VK, Lessard E, Pouliot J.

Int J Radiat Oncol Biol Phys. 2005 Nov 15;63(4):1270-4.

PMID:
16253782
15.

Quality assurance in the prospective multi-institutional trial on definitive radiotherapy using high-dose-rate intracavitary brachytherapy for uterine cervical cancer: the individual case review.

Toita T, Oguchi M, Ohno T, Kato S, Niibe Y, Kodaira T, Kazumoto T, Kataoka M, Shikama N, Kenjo M, Teshima T, Kagami Y.

Jpn J Clin Oncol. 2009 Dec;39(12):813-9. doi: 10.1093/jjco/hyp105.

17.

Inverse planning simulated annealing for magnetic resonance imaging-based intracavitary high-dose-rate brachytherapy for cervical cancer.

Kubicky CD, Yeh BM, Lessard E, Joe BN, Speight JL, Pouliot J, Hsu IC.

Brachytherapy. 2008 Jul-Sep;7(3):242-7. doi: 10.1016/j.brachy.2008.01.003.

PMID:
18468959
18.

HDR quality assurance methods for personal digital assistants.

Astrahan MA.

Med Dosim. 2004 Fall;29(3):166-72.

PMID:
15324912
19.
20.
Items per page

Supplemental Content

Support Center